MENU
FLNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Filana Therapeutics (FLNA) Ownership - Who owns Filana Therapeutics?

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A... Show more

Profile

Industry
Pharmaceuticals Other
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
59.66M
P/E Ratio
N/A
Total Cash
86.57M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash/Share
1.79
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
FLNA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of novel drugs

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A